Burns J W & CO Inc Abbott Laboratories Transaction History

Burns J W & CO Inc

$767 Million
Q3 2024

A detailed history of Burns J W & CO Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Burns J W & CO Inc holds 18,232 shares of ABT stock, worth $2.05 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

18,232

Previous 23,883 23.66%

Holding current value

$2.05 Million

Previous $2.48 Million 16.24%

% of portfolio

0.27%

Previous 0.34%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$100.07 - $118.13 $565,495 - $667,552	-5,651 Reduced 23.66%	18,232 $2.08 Million
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $586,651 - $654,850	-5,824 Reduced 19.6%	23,883 $2.48 Million
Q1 2024 Apr 17, 2024	SELL	$109.52 - $120.96 $512,991 - $566,576	-4,684 Reduced 13.62%	29,707 $3.38 Million
Q4 2023 Jan 18, 2024	SELL	$90.19 - $110.4 $112,737 - $138,000	-1,250 Reduced 3.51%	34,391 $3.79 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $361,294 - $433,492	-3,782 Reduced 9.59%	35,641 $3.45 Million
Q2 2023 Jul 12, 2023	SELL	$100.78 - $112.29 $185,838 - $207,062	-1,844 Reduced 4.47%	39,423 $4.3 Million
Q1 2023 Apr 17, 2023	SELL	$96.86 - $114.01 $27,992 - $32,948	-289 Reduced 0.7%	41,267 $4.18 Million
Q4 2022 Jan 13, 2023	SELL	$95.06 - $111.52 $116,828 - $137,058	-1,229 Reduced 2.87%	41,556 $4.56 Million
Q3 2022 Oct 04, 2022	SELL	$96.76 - $112.03 $723,474 - $837,648	-7,477 Reduced 14.88%	42,785 $4.14 Million
Q2 2022 Jul 14, 2022	SELL	$102.07 - $123.37 $81,553 - $98,572	-799 Reduced 1.56%	50,262 $5.46 Million
Q1 2022 Apr 08, 2022	SELL	$114.02 - $139.04 $195,658 - $238,592	-1,716 Reduced 3.25%	51,061 $6.04 Million
Q4 2021 Jan 20, 2022	SELL	$115.53 - $141.46 $189,931 - $232,560	-1,644 Reduced 3.02%	52,777 $7.43 Million
Q3 2021 Oct 13, 2021	BUY	$116.66 - $129.06 $206,954 - $228,952	1,774 Added 3.37%	54,421 $6.43 Million
Q2 2021 Jul 12, 2021	BUY	$105.79 - $124.53 $296,846 - $349,431	2,806 Added 5.63%	52,647 $6.1 Million
Q1 2021 Apr 16, 2021	BUY	$108.84 - $128.23 $120,594 - $142,078	1,108 Added 2.27%	49,841 $5.97 Million
Q4 2020 Jan 12, 2021	BUY	$105.0 - $114.42 $417,795 - $455,277	3,979 Added 8.89%	48,733 $5.34 Million
Q3 2020 Oct 06, 2020	BUY	$91.64 - $111.29 $98,971 - $120,193	1,080 Added 2.47%	44,754 $4.87 Million
Q2 2020 Jul 06, 2020	SELL	$76.57 - $98.0 $153 - $196	-2 Reduced -0.0%	43,674 $3.99 Million
Q1 2020 Apr 06, 2020	BUY	$62.82 - $91.86 $5,590 - $8,175	89 Added 0.2%	43,676 $3.45 Million
Q4 2019 Jan 07, 2020	BUY	$78.51 - $87.4 $48,911 - $54,450	623 Added 1.45%	43,587 $3.79 Million
Q3 2019 Oct 11, 2019	BUY	$81.84 - $88.74 $12,685 - $13,754	155 Added 0.36%	42,964 $3.6 Million
Q2 2019 Jul 09, 2019	BUY	$72.88 - $85.0 $48,683 - $56,780	668 Added 1.59%	42,809 $3.6 Million
Q1 2019 Apr 02, 2019	BUY	$66.22 - $80.06 $82,443 - $99,674	1,245 Added 3.04%	42,141 $3.37 Million
Q4 2018 Jan 16, 2019	BUY	$65.56 - $74.27 $1.04 Million - $1.18 Million	15,890 Added 63.54%	40,896 $2.96 Million
Q3 2018 Oct 05, 2018	BUY	$60.81 - $73.36 $47,735 - $57,587	785 Added 3.24%	25,006 $1.83 Million
Q2 2018 Jul 20, 2018	BUY	$57.57 - $63.54 $11,341 - $12,517	197 Added 0.82%	24,221 $1.48 Million
Q1 2018 Apr 04, 2018	BUY	$56.27 - $63.62 $64,429 - $72,844	1,145 Added 5.0%	24,024 $1.44 Million
Q4 2017 Jan 17, 2018	BUY	$53.68 - $57.47 $127,919 - $136,951	2,383 Added 11.63%	22,879 $1.31 Million
Q3 2017 Oct 10, 2017	BUY	$48.06 - $53.64 $985,037 - $1.1 Million	20,496	20,496 $1.09 Million

Others Institutions Holding ABT

# of Institutions

3,137

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burns J W & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Burns J W & CO Inc with notifications on news.

Account